Physician
Northern California Cancer Center
Northern California Cancer Center was paid $39.95M by Medicaid between Jan 2018 and Aug 2024, across 40 billing codes. Its largest line is J9264, Injection, paclitaxel protein-bound particles, 1 mg — 44% of everything it billed.
33Billing provider infoNORTHERN CALIFORNIA CANCER CENTER
MODESTO, CA 95350
MODESTO, CA 95350
33aNPI1447539374assigned 08/09/2011
33bProvider typeMedical Oncology Physician
28Total paid$39.95M
24GClaims225,024
24DCodes billed40
24AFirst – last monthJan 2018 – Aug 2024
Compared with peers
Next to other Medical Oncology Physician providers in California
Rank by total paid#1 of 33
Median peer was paid$29K
This provider vs. median1,362×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official WILLIAMS, ROBERT controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 53,096 | $10.66M | |
| 2019 | 45,149 | $9.08M | |
| 2020 | 34,425 | $6.65M | |
| 2021 | 27,782 | $5.13M | |
| 2022 | 26,339 | $3.26M | |
| 2023 | 24,748 | $3.50M | |
| 2024incomplete | 13,485 | $1.67M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 44% | 6,494 | 1,822 | $17.38M |
| J9299 | Injection, nivolumab, 1 mg | 20% | 1,610 | 880 | $8.13M |
| J9395 | Injection, fulvestrant, 25 mg | 5.9% | 1,963 | 1,837 | $2.34M |
| J9271 | Injection, pembrolizumab, 1 mg | 4.6% | 262 | 193 | $1.82M |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 4.1% | 1,029 | 225 | $1.64M |
| J2997 | Injection, alteplase recombinant, 1 mg | 3.6% | 20,138 | 7,826 | $1.43M |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.4% | 25,766 | 13,398 | $1.36M |
| J1453 | Injection, fosaprepitant, 1 mg | 2.1% | 2,113 | 1,035 | $824K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.0% | 14,949 | 4,704 | $801K |
| 36593 | 1.3% | 20,063 | 7,860 | $523K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 1.2% | 13,346 | 4,501 | $471K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1.2% | 8,229 | 3,719 | $468K |
28 more codes
| J9070 | Cyclophosphamide, 100 mg | 1.2% | 3,360 | $465K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 16,599 | $391K |
| J0897 | Injection, denosumab, 1 mg | <1% | 201 | $383K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 14,669 | $356K |
| 96367 | <1% | 8,185 | $238K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 18,240 | $144K |
| 96417 | <1% | 5,491 | $138K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,065 | $136K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 5,590 | $100K |
| 96415 | <1% | 3,809 | $93K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 3,065 | $68K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,098 | $47K |
| J3489 | Injection, zoledronic acid, 1 mg | <1% | 847 | $47K |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 8,003 | $32K |
| 99195 | <1% | 2,094 | $26K | |
| 96402 | <1% | 2,294 | $21K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 3,667 | $18K |
| J0640 | Injection, leucovorin calcium, per 50 mg | <1% | 147 | $14K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 646 | $14K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 293 | $10K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 1,467 | $7K |
| 96409 | <1% | 524 | $6K | |
| J9190 | Injection, fluorouracil, 500 mg | <1% | 119 | $4K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | <1% | 61 | $3K |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 45 | $2K |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | <1% | 338 | $1K |
| 96416 | <1% | 24 | $1K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 121 | $1K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWILLIAMS, ROBERT (CHARIMAN/CEO)
| Provider | Location | Paid |
|---|---|---|
| Arkansas Children's Medical Group PLLC | Little Rock, AR | $16.05M |
| Wayne County Dental Associates LLC | Richmond, IN | $1.66M |
| Cheryl G Williams DO PC | Mount Vernon, MO | $1.49M |
| Roadrunner Radiology Equipment, LLC | Bastrop, TX | $969K |
| Direct Medical Supplies, LLC | Memphis, TN | $768K |
| Kingstree Family Dentisry LLC | Kingstree, SC | $577K |
| Geriatric Neuropsychiatry Services, PLLC | Durham, NC | $484K |
| Village of Elmsford | Elmsford, NY | $67K |
| Arkansas Children's Medical Group PLLC | Rogers, AR | $22K |
| Socastee Eye Clinic INC | Myrtle Beach, SC | $10K |
| Lone Star House Call Physicians, LLC | Bastrop, TX | $5K |
| Bluefield Regional Medical Center | Bluefield, WV | $3K |
| Southwest Radiological Consultants LLC | Liberal, KS | $3K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.